Last reviewed · How we verify
NCT05353816
Corheart 6 Left Ventricular Assist System Prospective, Multicenter, Single-arm Clinical Evaluation Trial
NA trial testing Corheart 6 Left Ventricular Assist System in End-stage Heart Failure in 50 participants. Participants enrolled and being followed up; not accepting new ones.
30 September 2024
Quick facts
| Lead sponsor | Shenzhen Core Medical Technology CO.,LTD. |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 26 January 2022 |
| Primary completion | 30 September 2024 |
| Estimated completion | 1 October 2027 |
| Sites | 11 locations across China |
Drugs / interventions tested
- Corheart 6 Left Ventricular Assist System
Conditions studied
- End-stage Heart Failure — all drugs for End-stage Heart Failure →
Sponsor
Shenzhen Core Medical Technology CO.,LTD.
Who can join
18 and older, any sex, with End-stage Heart Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is to evaluate the safety and effectiveness of the Corheart 6 Left Ventricular Assist System (Corheart 6 LVAS) used for the treatment of end-stage heart failure.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Developments and Challenges in Durable Ventricular Assist Device Technology: A Comprehensive Review with a Focus on Advancements in China.
Tu J, Xu L, Li F, Dong N. · · 2024 · cited 4× · PMID 38248899 · DOI 10.3390/jcdd11010029 -
A novel magnetically levitated intrapericardial left ventricular assist system in advanced heart failure-2-year results from a prospective, multi-centre study.
Wang X, Chen H, Du J, Zhou X, et al · · 2026 · PMID 41512307 · DOI 10.1093/ejcts/ezag014
Verify or expand the search:
- PubMed search for NCT05353816
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Corheart 6 Left Ventricular Assist System
Trials testing the same drug.
- NCT05876000 — Corheart 6 LVAS Study · NA · recruiting
- NCT06267612 — Corheart 6 LVAS Long-term Follow-up Study · NA · not yet recruiting
- NCT05928273 — Corheart 6 LVAS LTFU · NA · completed
Other recruiting trials for End-stage Heart Failure
Currently open trials in the same condition.
- NCT07382284 — Long-Term Survival After LVAD Implantation in End-Stage Heart Failure · recruiting
Other Shenzhen Core Medical Technology CO.,LTD. trials
Trials by the same sponsor.
- NCT07233876 — DuoCor 2 DOMINATE Study · NA · not yet recruiting
- NCT06886113 — CorVad Myocardial Infarction Complicated with Cardiogenic Shock Trial · NA · not yet recruiting
- NCT06646224 — Efficacy and Safety of the CorVad Percutaneous Ventricular Assist System in Cardiogenic Shock · NA · recruiting
- NCT06878508 — DuoCor Ventricular Assist System Early Feasibility Study · NA · recruiting
- NCT05876000 — Corheart 6 LVAS Study · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05353816 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shenzhen Core Medical Technology CO.,LTD.
- Last refreshed: 2 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05353816.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing